Waleed Al Mokarrab Al Muhairi
Chairman
Mr. Al Muhairi serves as Mubadala’s Deputy Group Chief Executive Officer and has strategic oversight of the company’s broad investment portfolio and special projects at the group level. He is also a member of the investment committee, which is mandated to develop Mubadala’s investment policies, establish investment guidelines, and review proposed projects and investments to ensure they are in line with business objectives.
Mr. Al Muhairi is also the Chairman to Mubadala's new investment and business planning committee, which approves transactions within certain financial thresholds in addition to having the responsibility of annual and multi-year business planning. Furthermore, Mr. Al Muhairi has oversight of the UAE Investments, Real Estate & Infrastructure, and Disruptive business platforms. Prior to joining Mubadala, Mr. Al Muhairi worked with the UAE Offsets Programme Bureau as a Senior Project Manager. His roles also include working with McKinsey & Company as a consultant.
Mr. Al Muhairi is the Chairman of Cleveland Clinic Abu Dhabi, Waha Capital, Mubadala Capital, Global Institute for Disease Elimination (GLIDE), Mubadala Health, and the US-UAE Business Council. In addition, Mr. Al Muhairi is a member of the Board of Trustees of Cleveland Clinic in the United States. He is also a board member of Aldar, First Abu Dhabi Bank (FAB), Hub71, Ellipses Pharma Limited, Abu Dhabi Investment Council, Investcorp, Noon.com and Tamkeen.
Mr. Al Muhairi holds a Master’s Degree in Public Policy from Harvard University, and a Bachelor of Science Degree in Foreign Service in Economics and Finance from Georgetown University, USA.